The Journal of Physiology publishes research in all areas of physiology and pathophysiology that illustrates new physiological principles, mechanisms or premises. Papers on work at the molecular level, cell membrane, single cells, tissues or organs, and on systems physiology are all encouraged. We are particularly keen on research that has a clinical or translational focus, to help further our understanding of the role physiology plays in health and disease.

A publication of The Physiological Society

Featured in The Journal of Physiology

Browse Articles

Open access

Potassium homeostasis during disease progression of Alzheimer's disease

  •  14 May 2025

Graphical Abstract

Amyloid pathology in aged 5xFAD mice Reactive astrocytes in the hippocampus of 5xFAD mice Astrocytic K+ clearance in the hippocampus of 5xFAD mice Astrocytic K+ clearance in the somatosensory cortex of 5xFAD mice Expression of Kir4.1 channels in the hippocampus and somatosensory cortex of 5xFAD mice Membrane properties of neurons recorded from the stratum lacunosum moleculare layer of CA1 area Alterations in astrocytic K+ clearance affect neuronal signalling Potassium homeostasis during disease progression of Alzheimer's disease Issue ,

Abstract figure legend Schematic diagram depicting astrocytic potassium (K+) clearance in the hippocampus of healthy brain (left) and during progression of Alzheimer's disease. Reduced conductivity through Kir channels and gap junctions in hippocampal astrocytes impair their ability to clear K+ from the extracellular milleu, which results in a transient increase in extracellular K+ that affects the excitability profile of nearby neurons.

free access

Issue Information

  •  2465-2466
  •  13 May 2025
First page image
Open access

Early adversity and the comorbidity between metabolic disease and psychopathology

  •  11 May 2025

Graphical Abstract

Early-life adversity (ELA) in critical periods of development promotes adaptive changes that affect susceptible biological systems and mechanisms such as the hypothalamic-pituitary-adrenal (HPA) axis, immune-inflammatory pathways, neuroendocrine systems regulating energy metabolism (e.g. insulin, leptin) and cellular oxidative stress processes Insulin receptors are spread throughout the brain. Insulin signalling in key brain areas from the mesocorticolimbic system, such as the ventral tegmental area (VTA), nucleus accumbens (NAc) and the prefrontal cortex (PFC), modulates neurotransmitter systems such as the dopaminergic signalling Leptin sites of action on the periphery and the brain, influencing neurodevelopment and physical health after stress General mechanism by which variations in the quality of the early environment persistently modify the function of the hypothalamic-pituitary-adrenal (HPA) axis Gene–environment interactions in practice Early-life adversity (ELA) interacting with the individual genetic background during sensitive periods of development can induce immediate brain and metabolic adaptive responses that guarantee survival Early adversity and the comorbidity between metabolic disease and psychopathology Issue ,

Abstract figure legend Hierarchical diagram representing the interplay between the genetic background and early life adversities and its effect on multiple physiological processes that ultimately impact on the risk for the comorbdity between psychopathology and cardiometabolic disorders.

A polygenetic rat model of divergent aerobic capacity reveals a liver–brain interaction impacting Alzheimer's disease-like phenotypes

  •  11 May 2025

Graphical Abstract

Aerobic capacity, diet and sex alter faecal, serum and liver bile acid content Aerobic capacity, diet and sex alter brain Aβ homeostasis Aerobic capacity, diet and sex alter liver Aβ homeostasis Aerobic capacity, diet and sex alter brain and liver mitochondrial function Aerobic capacity, diet and sex alter brain and hippocampal volume and cognition Aerobic capacity and sex alter left hippocampal metabolites Aerobic capacity, diet and sex alter left hippocampal metabolites A polygenetic rat model of divergent aerobic capacity reveals a liver–brain interaction impacting Alzheimer's disease-like phenotypes Issue ,

Abstract figure legend This study examined the effects of aerobic capacity diet, and sex on brain and liver health in the context of the Alzheimer's disease (AD) biomarker amyloid beta (Aβ42). The data suggest reduced liver health with a high-fat diet (HFD) and reduced aerobic capacity leads to increased peripheral amyloid beta compared to a low- fat diet (LFD) with high aerobic capacity. Brain amyloid beta load was also influenced by diet and aerobic capacity-induced alterations to liver health. These data highlight the importance in understanding systemic contributions to AD biomarkers and pathologies.

free access

Tumour necrosis factor‐alpha at the intersection of renal epithelial and immune cell function

  •  11 May 2025

Graphical Abstract

Effects of TNF on renal transporters Proposed interactions of UMOD and TNF that regulate blood pressure NFAT5 optimizes T cell and TEC function Effects of etanercept on blood pressure and renal damage Tumour necrosis factor-alpha at the intersection of renal epithelial and immune cell function Issue ,

Abstract figure legend Tumour necrosis factor-alpha (TNF), produced by tubular epithelial cells (TECs), plays a critical role in regulating ion transport pathways along the nephron via autocrine and paracrine mechanisms. Its effects depend on the stimulus, the amount of TNF generated and the presence or absence of ongoing renal inflammation. Under homeostatic conditions, TNF can act as a braking mechanism to maintain balance. However, in inflammatory settings, it may contribute to renal damage and dysfunction. Additionally, TNF modulates interactions between TECs and infiltrating immune cells, influencing the resolution or exacerbation of inflammatory responses in the kidney.

Open access

Re: JP‐TR‐2024‐286891 ‘The ageing brain: Cortical overactivation – How does it evolve?’

  •  11 May 2025

Graphical Abstract

This figure shows a selection of the most important changes in the central nervous system (i.e. neural correlates of ageing) that may influence motor control (i.e. behavioural correlates of aging) Model for the development of age-related overactivation: from compensation to maladaptive overcompensation Empirical evidence of changes in brain activation with increasing age depending on task difficulty Re: JP-TR-2024-286891 ‘The ageing brain: Cortical overactivation – How does it evolve?’ Issue ,

Abstract figure legend Age-related progression of brain activity over time. This review article proposes a developmental process in the ageing brain, from compensation to negative overcompensation to chronic maladaptive overcompensation, which leads to dedifferentiation and desegregation. When comparing brain activation patterns in young and old for the same ‘absolute task difficulty’, shifts in brain activity from an automatic, lower level towards a more cortically controlled, attention-demanding control of motor actions can be seen, resulting in more bilateral and frontal activation patterns in the elderly (see changes in red activation hotspots in the figure). Importantly elderly subjects utilize motor control strategies, such as increased cortical activity, down-regulation of inhibitory processes and less-segregated and lateralized brain activation patterns, that can also be found in healthy young adults when task challenges increase. We propose that this age-related strategy is beneficial and compensatory to account for the perceived increases in ‘relative task difficulty’. However with progression of ageing and deterioration of the central nervous system, this compensatory brain activity may turn into non-efficient overactivation, already apparent during execution of the very simplest motor tasks.

Open access

Adverse effects of high‐fat diet consumption on contractile mechanics of isolated mouse skeletal muscle are reduced when supplemented with resveratrol

  •  2675-2698
  •  11 May 2025

Graphical Abstract

Example Extensor digitorum longus (A) and soleus (B) work loops Effect of 12 weeks high-fat diet and resveratrol on mouse body mass The effect of 12 weeks high-fat diet and resveratrol on isolated mouse EDL and SOL isometric function The effect of 12 weeks high-fat diet and resveratrol on isolated mouse EDL and SOL passive net work The effect of 12 weeks high-fat diet and resveratrol on isolated mouse EDL and SOL work loop power The effect of stimulation frequency, and 12 weeks high-fat diet and resveratrol on the maximal work loop power output of mouse EDL and SOL The effect of 12 weeks high-fat diet and resveratrol on fatigue resistance and recovery of isolated mouse EDL and SOL Effects of 12 weeks high-fat diet and resveratrol on work loop shapes during assessment of fatigue The effect of 12 weeks high-fat diet and resveratrol on the ratio of SIRT1/GAPDH of isolated mouse EDL (A) and SOL (B) Adverse effects of high-fat diet consumption on contractile mechanics of isolated mouse skeletal muscle are reduced when supplemented with resveratrol Issue 9, 2025

Abstract figure legend An evaluation of the effectiveness of resveratrol as an anti-obesogenic nutritional strategy to mitigate the adverse effects of a high-fat diet on skeletal muscle health. Resveratrol, when consumed with a high-fat diet, reduces adipose accumulation in female CD-1 mice (∼18 weeks old), compared to a high-fat diet only. Using the work loop technique, we further show that resveratrol preserves fast-twitch extensor digitorum longus (EDL) muscle function by preventing the high-fat diet-induced decline in acute power output and cumulative work during fatiguing contractions. Notably, EDL performance in the high-fat diet + resveratrol group was comparable to that of standard laboratory diet-fed mice. Resveratrol did not alter skeletal muscle morphology or contractility when consumed with a standard laboratory diet. Despite previous reports linking resveratrol's anti-obesogenic effects to increased expression of silent information regulator 2 mammalian ortholog (SIRT1), we found no difference in SIRT1 protein expression in isolated soleus and EDL muscles across all groups. These findings suggest that resveratrol could be an effective nutritional strategy in negating some of the detrimental effects of high-fat diet consumption on skeletal muscle health.

Open access

In silico modelling of multi-electrode arrays for enhancing cardiac drug testing on hiPSC-CM heterogeneous tissues

  •  11 May 2025

Graphical Abstract

Schematic representation of the MEA device Heterogenous tissue configuration Phenotype-specific ionic models Activation time maps Local conduction speed maps Repolarization time maps APD time maps Heterogeneity effect on the average conduction velocity; AP and FP in the nine electrodes Ionic model comparison for healthy and BrS1- or BrS2-affected VL hiPSC-CMs Electrical activity in the selected electrode Local conduction speed map comparison Mexiletine effect Dofetilide effect Nifedipine effect E-4031 effect In silico modelling of multi-electrode arrays for enhancing cardiac drug testing on hiPSC-CM heterogeneous tissues Issue ,

Abstract figure legend Schematic overview of the experimental and computational framework for investigating hiPSC-CM electrophysiology with MEA systems. The MEA-based model integrates experimental data with phenotype-specific ionic models and tissue-level heterogeneity. Colour-coded maps highlight the impact of heterogeneity on conduction velocity, which increases with a higher percentage of atrial-like (AL) cells. Brugada syndrome simulations reveal locally reduced conduction velocity, consistent with adult tissue observations. Drug simulations for mexiletine, dofetilide, nifedipine and E-4031 demonstrate the model's capability to predict extracellular potential changes and ionic current dynamics. This integrative framework offers a comprehensive approach to assess disease-specific and pharmacological electrophysiological responses.

Open access

Elucidating the cellular determinants of the end‐systolic pressure‐volume relationship of the heart via computational modelling

  •  11 May 2025

Graphical Abstract

Representation of the end-systolic pressure-volume (ESPV) relationship and shortening deactivation/activation Left ventricle model and cell scale model Representation of the metrics used to quantify the impact of shortening upon contractility Left ventricle model results for changes in cross-bridge (XB) kinetics cell scale model results for changes in cross-bridge (XB) kinetics Left ventricle model results for changes in calcium transient (CaT) duration (at constant CaT amplitude) cell scale model results for changes in calcium transient (CaT) duration (at constant CaT amplitude) Left ventricle model results for changes in calcium transient (CaT) duration (with CaT amplitude correction) Cell scale model results for changes in calcium transient (CaT) duration (with CaT amplitude correction) Deeper investigation of microscale variables Elucidating the cellular determinants of the end-systolic pressure-volume relationship of the heart via computational modelling Issue ,

Abstract figure legend Using a multiscale computational model of left ventricular electromechanics, we investigated how sarcomere dynamics influence the end-systolic pressure-volume (ESPV) relationship in ejecting beats compared to isovolumetric beats. Our results indicate that the ejecting ESPV relationship emerges from the interplay of two opposing mechanisms. On one hand, ejecting beats exhibit a memory effect due to the higher thin filament activation in early systole, driven by the increased apparent calcium sensitivity at high sarcomere length (SL), leading to pressure enhancement. On the other hand, fibre shortening limits cross-bridge (XB) cycling efficiency through to the well-known inverse force-velocity relationship, resulting in pressure attenuation. When the first mechanism outweighs the second, ejection has a net activating effect, causing the ejecting ESPV relationship to exceed the isovolumetric one. Conversely, when the second mechanism dominates, shortening has a deactivating effect. In particular the first mechanism is enhanced by a prolonged calcium transient, whereas the second is favoured by reduced XB kinetics.

Open access

Acute ketone monoester ingestion lowers resting cerebral blood flow: a randomized cross‐over trial

  •  11 May 2025

Graphical Abstract

Trial flowchart Schematic overview of the experimental protocol Plasma β-OHB concentrations after acute ketone monoester supplement (KME) ingestion Global CBF (gCBF) responses to acute ketone monoester supplement (KME) ingestion Relationship between end-tidal CO2 and global CBF (gCBF) Exploratory correlations Acute ketone monoester ingestion lowers resting cerebral blood flow: a randomized cross-over trial Issue ,

Abstract figure legend This double-blind, placebo-controlled, randomized cross-over trial investigated the effects of ketone monoester (KME) ingestion on resting cerebral blood flow (CBF) in young adults. We demonstrate that KME supplementation lowers CBF in a dose-dependent manner over 2-houra post-ingestion, whereas CBF remained unchanged following placebo ingestion. KME ingestion also lowered end-tidal CO2 in a dose-dependent manner. KME ingestion increased heart rate but did not affect mean arterial pressure. KME, ketone monoester; CBF, cerebral blood flow; ICA, internal carotid artery; VA, vertebral artery.

More articles
More articles

Latest news